[Insulin resistance in patients with type 1 diabetes]
Related Experiment Video
Updated: Jun 20, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Aleksandra Uruska1, Aleksandra Araszkiewicz
1Katedra i Klinika Chorób Wewnetrznych i Diabetologii Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu, Poznań. aleksandrauruska@gmail.com
Abstract:
Insulin determines glucose transport to the most of cells. Decreased answer of target cells to insulin is called insulin resistance. This phenomenon depends on genetic and environmental factors. The most important risk factor of progression of insulin resistance is style of life created by civilizational progress. The coexistence of insulin resistance, obesity, diabetes mellitus, hypertension and dyslipidaemia is defined as metabolic syndrome. At the beginning decreased insulin sensitivity was linked only with obesity and diabetes type 2. However clinical features of insulin resistance are present also in many patients with type 1 diabetes. In pathogenesis of insulin resistance decreased number of insulin's binding places and postreceptor function's failure are mentioned. It was revealed that diminished glucose disposal in the organism is an effect of reduced glucose uptake in the skeletal muscle. There are different methods of insulin resistance's assessment, however in patients with type 1 diabetes not all of them can be used. The gold standard of determining insulin sensitivity is the euglycemic insulin clamp technique. Other methods of insulin resistance's evaluation which will be more available, easier and cheaper are searched. Thus, indirect parameters of insulin resistance such as: anthropometric data, features of metabolic syndrome or inflammatory markers, correlated with clamp technique results are suggested to be used. Insulin resistance in type 1 diabetes is an extremely important clinical aspect because it increases the risk of chronic complications' development. Identification of insulin resistant patient with type 1 diabetes is essential for better metabolic control and prevention of longterm complications in this group.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes I: Introduction
